List of Tables
Table 1. Non-invasive Vaccine Market Trends
Table 2. Non-invasive Vaccine Market Drivers & Opportunity
Table 3. Non-invasive Vaccine Market Challenges
Table 4. Non-invasive Vaccine Market Restraints
Table 5. Global Non-invasive Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Non-invasive Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Global Non-invasive Vaccine Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Non-invasive Vaccine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Non-invasive Vaccine Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Non-invasive Vaccine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Non-invasive Vaccine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Non-invasive Vaccine
Table 13. Global Non-invasive Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Vaccine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-invasive Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Non-invasive Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Non-invasive Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Non-invasive Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Non-invasive Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Non-invasive Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Non-invasive Vaccine Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Non-invasive Vaccine Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Non-invasive Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Non-invasive Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Non-invasive Vaccine Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Non-invasive Vaccine Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Non-invasive Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Non-invasive Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Non-invasive Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Non-invasive Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Non-invasive Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Non-invasive Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Non-invasive Vaccine Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Non-invasive Vaccine Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Non-invasive Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Non-invasive Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Non-invasive Vaccine Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Non-invasive Vaccine Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Non-invasive Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Non-invasive Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Non-invasive Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Non-invasive Vaccine Sales Value by Region (2019-2024) & (%)
Table 44. Global Non-invasive Vaccine Sales Value by Region (2025-2030) & (%)
Table 45. Global Non-invasive Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Non-invasive Vaccine Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Non-invasive Vaccine Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Non-invasive Vaccine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Non-invasive Vaccine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Non-invasive Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Non-invasive Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Non-invasive Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Non-invasive Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Non-invasive Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Non-invasive Vaccine Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Non-invasive Vaccine Sales Volume, (2025-2030) & (K Units)
Table 57. Merck Company Information
Table 58. Merck Introduction and Business Overview
Table 59. Merck Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Merck Non-invasive Vaccine Product Offerings
Table 61. Merck Recent Development
Table 62. GSK Company Information
Table 63. GSK Introduction and Business Overview
Table 64. GSK Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. GSK Non-invasive Vaccine Product Offerings
Table 66. GSK Recent Development
Table 67. Sanofi Company Information
Table 68. Sanofi Introduction and Business Overview
Table 69. Sanofi Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Sanofi Non-invasive Vaccine Product Offerings
Table 71. Sanofi Recent Development
Table 72. Lanzhou Institute Company Information
Table 73. Lanzhou Institute Introduction and Business Overview
Table 74. Lanzhou Institute Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Lanzhou Institute Non-invasive Vaccine Product Offerings
Table 76. Lanzhou Institute Recent Development
Table 77. Serum Institute Company Information
Table 78. Serum Institute Introduction and Business Overview
Table 79. Serum Institute Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Serum Institute Non-invasive Vaccine Product Offerings
Table 81. Serum Institute Recent Development
Table 82. Valneva Company Information
Table 83. Valneva Introduction and Business Overview
Table 84. Valneva Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Valneva Non-invasive Vaccine Product Offerings
Table 86. Valneva Recent Development
Table 87. Shanghai United Cell Company Information
Table 88. Shanghai United Cell Introduction and Business Overview
Table 89. Shanghai United Cell Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Shanghai United Cell Non-invasive Vaccine Product Offerings
Table 91. Shanghai United Cell Recent Development
Table 92. Bibcol Company Information
Table 93. Bibcol Introduction and Business Overview
Table 94. Bibcol Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Bibcol Non-invasive Vaccine Product Offerings
Table 96. Bibcol Recent Development
Table 97. PaxVax Company Information
Table 98. PaxVax Introduction and Business Overview
Table 99. PaxVax Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. PaxVax Non-invasive Vaccine Product Offerings
Table 101. PaxVax Recent Development
Table 102. Vabiotech Company Information
Table 103. Vabiotech Introduction and Business Overview
Table 104. Vabiotech Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Vabiotech Non-invasive Vaccine Product Offerings
Table 106. Vabiotech Recent Development
Table 107. Tiantan Biological Company Information
Table 108. Tiantan Biological Introduction and Business Overview
Table 109. Tiantan Biological Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Tiantan Biological Non-invasive Vaccine Product Offerings
Table 111. Tiantan Biological Recent Development
Table 112. EuBiologics Company Information
Table 113. EuBiologics Introduction and Business Overview
Table 114. EuBiologics Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. EuBiologics Non-invasive Vaccine Product Offerings
Table 116. EuBiologics Recent Development
Table 117. Panacea Biotec Ltd Company Information
Table 118. Panacea Biotec Ltd Introduction and Business Overview
Table 119. Panacea Biotec Ltd Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Panacea Biotec Ltd Non-invasive Vaccine Product Offerings
Table 121. Panacea Biotec Ltd Recent Development
Table 122. Bio-Med Company Information
Table 123. Bio-Med Introduction and Business Overview
Table 124. Bio-Med Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Bio-Med Non-invasive Vaccine Product Offerings
Table 126. Bio-Med Recent Development
Table 127. Halfkin Bio-Pharmaceuticals Company Information
Table 128. Halfkin Bio-Pharmaceuticals Introduction and Business Overview
Table 129. Halfkin Bio-Pharmaceuticals Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Halfkin Bio-Pharmaceuticals Non-invasive Vaccine Product Offerings
Table 131. Halfkin Bio-Pharmaceuticals Recent Development
Table 132. AstraZeneca Company Information
Table 133. AstraZeneca Introduction and Business Overview
Table 134. AstraZeneca Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. AstraZeneca Non-invasive Vaccine Product Offerings
Table 136. AstraZeneca Recent Development
Table 137. Cipla Company Information
Table 138. Cipla Introduction and Business Overview
Table 139. Cipla Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Cipla Non-invasive Vaccine Product Offerings
Table 141. Cipla Recent Development
Table 142. BCHT Company Information
Table 143. BCHT Introduction and Business Overview
Table 144. BCHT Non-invasive Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. BCHT Non-invasive Vaccine Product Offerings
Table 146. BCHT Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Non-invasive Vaccine Downstream Customers
Table 150. Non-invasive Vaccine Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-invasive Vaccine Product Picture
Figure 2. Global Non-invasive Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Non-invasive Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Non-invasive Vaccine Sales Volume (2019-2030) & (K Units)
Figure 5. Global Non-invasive Vaccine Sales Price (2019-2030) & (US$/Unit)
Figure 6. Non-invasive Vaccine Report Years Considered
Figure 7. Global Non-invasive Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Non-invasive Vaccine Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-invasive Vaccine Revenue in 2023
Figure 10. Non-invasive Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Oral Vaccine Picture
Figure 12. Nasal Spray Vaccine Picture
Figure 13. Global Non-invasive Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Non-invasive Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Non-invasive Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Non-invasive Vaccine Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Non-invasive Vaccine Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Public
Figure 19. Product Picture of Private
Figure 20. Global Non-invasive Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Non-invasive Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Non-invasive Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Non-invasive Vaccine Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Non-invasive Vaccine Price by Application (2019-2030) & (US$/Unit)
Figure 25. North America Non-invasive Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Non-invasive Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Non-invasive Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Non-invasive Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Non-invasive Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Non-invasive Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Non-invasive Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Non-invasive Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Non-invasive Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Non-invasive Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Non-invasive Vaccine Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Non-invasive Vaccine Sales Volume (%), (2019-2030)
Figure 37. United States Non-invasive Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Non-invasive Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Non-invasive Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Non-invasive Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Non-invasive Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Non-invasive Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 43. China Non-invasive Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Non-invasive Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 45. China Non-invasive Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Non-invasive Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Non-invasive Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Non-invasive Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Non-invasive Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Non-invasive Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Non-invasive Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Non-invasive Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Non-invasive Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Non-invasive Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 55. India Non-invasive Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Non-invasive Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 57. India Non-invasive Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 58. Non-invasive Vaccine Industrial Chain
Figure 59. Non-invasive Vaccine Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
